glp-1 brain inflammation Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure A New Treatment Strategy for
Description
But it can also lead to unexpected or unadvertised side effects
Higher doses cause more inhibition in this dose-dependent effect
Add to basket
This article examines the relationship between GLP-1 therapy and dyspnea, reviews clinical evidence, and provides guidance on managing respiratory symptoms during treatment
doi: 10.1073/pnas.0610787104 195 MerchenthalerILaneMVNumanSDellovadeTL
